TaiwanJ Pharmaceuticals Co Ltd

NEW
ROCO:6549 (Taiwan)  
NT$ 7.09 -0.030 (-0.42%) Jul 14
At Loss
P/B:
8.02
Market Cap:
NT$ 568.07M ($ 17.65M)
Enterprise V:
NT$ 502.03M ($ 15.60M)
Volume:
45.02K
Avg Vol (2M):
152.56K
Trade In:
Volume:
45.02K
At Loss
Avg Vol (2M):
152.56K

TaiwanJ Pharmaceuticals Co Ltd’s share price is NT$7.09. Its GF Value is NT$11.99. Based on the relationship between the current stock price and the GF Value, GuruFocus believes TaiwanJ Pharmaceuticals Co Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: NT$7.09 GF Value Price/GF Value
Current NT$11.99 0.59
Next FY1 End NT$11.99 0.59
Next 12 Month NT$11.99 0.59
Next FY2 End NT$11.99 0.59
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing TaiwanJ Pharmaceuticals Co Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between TaiwanJ Pharmaceuticals Co Ltd's stock price and Revenue per share, with a coefficient of 81%. This is followed by a 79% correlation with Operating Cash Flow per share. TaiwanJ Pharmaceuticals Co Ltd’s stock price shows no significant correlation with Book Value per share. TaiwanJ Pharmaceuticals Co Ltd’s stock price shows no significant correlation with Earnings without NRI per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies